Skip to main content

Table 2 Neudesin concentration [ng/mL] obtained in serum, CSF, and Quotient value of patients with CNS tumors compared to non-tumoral individuals

From: Serum and cerebrospinal fluid Neudesin concentration and Neudesin Quotient as potential circulating biomarkers of a primary brain tumor

  Total brain tumor Astrocytic brain tumor Meningeal tumor Non-tumoral group
Serum 1.16 (0.94–1.68)# 1.24 (0.92–1.90) 1.07 (0.96–1.37)# 1.47 (1.39–1.99)
CSF 1.18 (0.80–2.17) 1.31 (0.93–2.17)# 0.66 (0.28–1.79) 0.98 (0.78–1.12)
Quotient 0.98 (0.47–1.33) 0.99 (0.78–1.33)# 0.62 (0.28–1.41) 0.56 (0.43–1.00)
  1. #statistically significant versus non-tumoral group (P < 0.05)
  2. Results are presented as median and interquartiles